| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84571-140-02 | 84571-140 | HUMAN PRESCRIPTION DRUG | ZIMHI | Naloxone Hydrochloride | INJECTION, SOLUTION | INTRAMUSCULAR; SUBCUTANEOUS | 20220115 | N/A | NDA | NDA212854 | ZMI Pharma Inc. | NALOXONE HYDROCHLORIDE | 5 mg/.5mL | 2 CASE in 1 CARTON (84571-140-02) / 1 SYRINGE in 1 CASE / .5 mL in 1 SYRINGE |
| 84571-140-11 | 84571-140 | HUMAN PRESCRIPTION DRUG | ZIMHI | Naloxone Hydrochloride | INJECTION, SOLUTION | INTRAMUSCULAR; SUBCUTANEOUS | 20220115 | N/A | NDA | NDA212854 | ZMI Pharma Inc. | NALOXONE HYDROCHLORIDE | 5 mg/.5mL | 1 CASE in 1 CARTON (84571-140-11) / 1 SYRINGE in 1 CASE / .5 mL in 1 SYRINGE |
| 78670-140-02 | 78670-140 | HUMAN PRESCRIPTION DRUG | Zimhi | NALOXONE HYDROCHLORIDE | INJECTION, SOLUTION | INTRAMUSCULAR; SUBCUTANEOUS | 20220331 | 20251031 | NDA | NDA212854 | USWM, LLC | NALOXONE HYDROCHLORIDE | 5 mg/.5mL | 2 CASE in 1 CARTON (78670-140-02) / 1 SYRINGE in 1 CASE (78670-140-11) / .5 mL in 1 SYRINGE |